ARTUSI, CARLO ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.075
AS - Asia 1.190
EU - Europa 1.130
Continente sconosciuto - Info sul continente non disponibili 209
SA - Sud America 153
AF - Africa 68
OC - Oceania 5
Totale 5.830
Nazione #
US - Stati Uniti d'America 2.971
SG - Singapore 502
IT - Italia 452
RU - Federazione Russa 398
CN - Cina 184
VN - Vietnam 156
HK - Hong Kong 114
BR - Brasile 106
BD - Bangladesh 99
GB - Regno Unito 73
CA - Canada 44
DE - Germania 39
FR - Francia 38
NL - Olanda 25
FI - Finlandia 23
IN - India 20
MX - Messico 20
ID - Indonesia 17
KR - Corea 15
IQ - Iraq 14
ZA - Sudafrica 13
NG - Nigeria 12
BJ - Benin 11
ES - Italia 11
IE - Irlanda 10
JP - Giappone 10
PK - Pakistan 10
AR - Argentina 9
AT - Austria 9
SA - Arabia Saudita 9
SE - Svezia 9
EC - Ecuador 8
MY - Malesia 8
TG - Togo 8
TR - Turchia 8
CO - Colombia 7
JM - Giamaica 7
NI - Nicaragua 7
PH - Filippine 7
PL - Polonia 7
UA - Ucraina 7
VE - Venezuela 7
CL - Cile 6
DZ - Algeria 6
AU - Australia 5
CH - Svizzera 5
EE - Estonia 4
MA - Marocco 4
PE - Perù 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
LT - Lituania 3
BE - Belgio 2
BO - Bolivia 2
BS - Bahamas 2
BZ - Belize 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PY - Paraguay 2
RO - Romania 2
SC - Seychelles 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
LY - Libia 1
MD - Moldavia 1
NA - Namibia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.620
Città #
San Jose 670
Dallas 666
Council Bluffs 365
Singapore 330
Ashburn 317
Verona 184
Moscow 146
Hong Kong 107
Ho Chi Minh City 55
New York 50
Santa Clara 49
McKinney 46
Hanoi 40
Beijing 34
Milan 34
Los Angeles 32
Phoenix 31
Buffalo 26
North Hollywood 22
Annandale 21
Chicago 19
The Dalles 18
Rome 17
Bologna 16
Houston 16
London 15
Naples 15
Chandler 13
Turin 13
São Paulo 12
Cotonou 11
Toronto 11
Abuja 10
Cleveland 10
Denver 10
Helsinki 10
Lappeenranta 10
Amsterdam 9
Atlanta 9
Haiphong 9
Jakarta 9
Brooklyn 8
Da Nang 8
Dublin 8
Lomé 8
Redondo Beach 8
Tokyo 8
Jacksonville 7
Mexico City 7
Montreal 7
Nuremberg 7
Southend 7
Baghdad 6
Managua 6
Munich 6
Philadelphia 6
Agrolândia 5
Biên Hòa 5
Cape Town 5
Caracas 5
Des Moines 5
Geneva 5
Madrid 5
Redmond 5
Vienna 5
Brasília 4
Dhaka 4
Falkenstein 4
Florence 4
Kuala Lumpur 4
Las Vegas 4
Manchester 4
North Bergen 4
Poplar 4
Princeton 4
Queens 4
Riyadh 4
Roncà 4
San Francisco 4
San Salvador 4
Stockholm 4
Warsaw 4
Albuquerque 3
Algiers 3
Belo Horizonte 3
Charlotte 3
City of London 3
Columbus 3
Fort Lauderdale 3
Glasgow 3
Guangzhou 3
Islamabad 3
Jackson 3
Jeddah 3
Kingston 3
Kyiv 3
Lawrence 3
Louisville 3
Marseille 3
Orem 3
Totale 3.761
Nome #
The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease 378
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 365
Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation 142
Dynamic Video Assessment of Axial Postural Abnormalities in Parkinson's Disease: A Pilot Study 136
Assessment of axial postural abnormalities in Parkinsonism: automatic picture analysis software 135
Advances in diagnosis, classification, and management of pain in Parkinson's disease 132
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model 132
Axial postural abnormalities in Parkinsonism: gaps in predictors, pathophysiology, and management 126
Does the degree of trunk bending predict patient disability, motor impairment, falls, and back pain in Parkinson's Disease? 113
Clinical Algorithm-Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease 112
Postural abnormalities in Parkinson's Disease: an epidemiological and clinical multicenter study 112
Longitudinal assessment of Botulinum Toxin treatment for lateral trunk flexion and Pisa Syndrome in Parkinson's Disease: real-life, long-term study 108
Task force consensus on nosology and cut-off values for axial postural abnormalities in parkinsonism 107
Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease 106
Botulinum toxin for axial postural abnormalities in Parkinson's Disease: a systematic review 105
Predictors and pathophysiology of axial postural abnormalities in Parkinsonism: a scoping review 104
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease 83
Treatment of axial postural abnormalities in parkinsonism disorders: A systematic review of pharmacological, rehabilitative and surgical interventions 80
Filling the gap in assessing pain in dystonia 79
Reply: "Human Pose Estimation Is Approximate: Limitations and Considerations for its Use in Clinical Trials" 79
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 52
A multi-level annotated sensor dataset of gait freezing manifestations and severity in Parkinson's disease 51
Placebo Responses in Trials of Functional Neurologic Disorders 48
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 46
Does sex influence the natural history of idiopathic adult-onset dystonia? 42
Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia? 42
From RGB-D to RGB-Only: Reliability and Clinical Relevance of Markerless Skeletal Tracking for Postural Assessment in Parkinson’s Disease 40
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson?s disease patients 36
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 36
Clinical MRI to predict motor and non-motor effects of deep brain stimulation in Parkinson disease 35
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up 35
Incidence and predictors of postural abnormalities in Parkinson?s disease: a PPMI cohort study 34
CACNA1A variant associated with generalized dystonia 33
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 33
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson?s disease 33
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 32
A new index to assess turning quality and postural stability in patients with Parkinson{'}s disease 31
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 31
Detection of Freezing of Gait in People with Parkinson{'}s Disease using Smartphones 31
Long-term motor and cognitive outcome of Deep Brain Stimulation in GBA-PD: the Italian PARKNET study 31
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab 30
Burden of caregiving for cardiovascular dysautonomia in Parkinson?s disease 30
Biomechanical assessment of botulinum toxin effects in Pisa syndrome disease 30
Nonmotor fluctuations in Parkinson's disease: impact on caregiving and quality of life 29
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson?s disease 29
Expanded and independent validation of the NoMoFA scale for Parkinson?s disease: the Italian version 29
Gait and axial postural abnormalities correlations in Parkinson{'}s disease: A multicenter quantitative study 29
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 28
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson?s disease patient with Parkin gene mutation: a case report 28
Smartphone-Based Evaluation of Postural Stability in Parkinson’s Disease Patients During Quiet Stance 28
Effect of deep brain stimulation frequency on gait symmetry, smoothness and variability using IMU 28
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 28
Editorial: Digital biomarkers in movement disorders 28
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 28
Digital work engagement among Italian neurologists 28
Speech Impairment in Parkinson's Disease: Acoustic Analysis of Unvoiced Consonants in Italian Native Speakers 28
Subthalamic and Nigral Stimulation for Freezing of Gait in Parkinson disease: randomized pilot trial 27
(Re)configuration of digital health records to optimize diagnosis and therapy 27
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild {COVID}-19 infection 27
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 27
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements 27
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 27
Postural abnormalities in Asian and Caucasian Parkinson{\textquotesingle}s disease patients: A multicenter study 27
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson?s disease 26
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 26
The still under-investigated role of cognitive deficits in PML diagnosis 26
Levodopa-Induced Neuropathy: A Systematic Review 26
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 25
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 25
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson{'}s disease: A different long-term outcome? 25
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 25
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: A 7-year experience 25
Behind the scenes: exploring neurological journal editors{'} work habits, decisions, and potential sources of conflict of interest 25
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson{'}s disease 25
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson{'}s disease 25
Natalizumab in multiple sclerosis: Long-term management 24
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to alzheimer's disease: Implications for treatment 24
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: A role for age at disease onset? 24
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases 24
The relationship between occupation and specific forms of idiopathic adult-onset dystonia 24
Should we offer deep brain stimulation to Parkinson?s disease patients with GBA mutations? 23
Tuning deep brain stimulation related depression by frequency modulation: A case report 23
Parkinson{'}s disease progression at 30 years: A study of subthalamic deep brain-stimulated patients 23
Predictors of cognitive performance in idiopathic adult-onset dystonia 23
Deep Brain Stimulation Selection Criteria for Parkinson's Disease: Time to Go beyond CAPSIT-PD 23
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 23
Deep brain stimulation for atypical parkinsonism: A systematic review on efficacy and safety 23
Ultrasound-guided botulinum toxin-a injections: A method of treating sialorrhea 22
Early Detection of Dysphagia Signs in Parkinson’s Disease: An Artificial Intelligence-Based Approach Using Non-Invasive Sensors 22
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 22
Subthalamic deep brain stimulation and levodopa in Parkinson?s disease: a meta-analysis of combined effects 22
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors 22
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 22
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report 22
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 21
Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa 21
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 21
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 21
Multicenter validation of the Italian Pain in Dystonia Scale in idiopathic adult-onset cervical dystonia 21
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 21
Totale 4.998
Categoria #
all - tutte 32.162
article - articoli 31.734
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 428
Totale 64.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 2 0 1 2 5
2022/202351 3 8 4 5 4 10 1 2 3 4 4 3
2023/202478 5 3 6 9 8 21 8 2 0 4 6 6
2024/2025306 16 11 16 42 15 6 15 23 41 24 30 67
2025/20263.884 70 63 644 180 426 110 151 1.015 520 383 143 179
2026/20271.453 202 267 341 643 0 0 0 0 0 0 0 0
Totale 5.830